• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The alpha-lipoic acid derivative DHLHZn: a new therapeutic agent for acute lung injury in vivo

Research Project

Project/Area Number 16K20399
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Emergency medicine
Research InstitutionKeio University

Principal Investigator

Shoji Yoshiaki  慶應義塾大学, 医学部(信濃町), 助教 (90626706)

Project Period (FY) 2016-04-01 – 2018-03-31
Project Status Completed (Fiscal Year 2017)
Budget Amount *help
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2017: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2016: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Keywordsαリポ酸 / 急性肺障害 / DHLHZn / ARDS / ALI / 急性呼吸促迫症候群 / 急性肺傷害
Outline of Final Research Achievements

Acute lung injury (ALI) is an inflammatory response of the lungs to both direct and indirect insults such as pneumonia, sepsis, trauma, and highly invasive surgeries, and further progress in prevention and treatment is required.
In this study, an animal experiment was performed to demonstrate the anti-inflammatory effects of an alpha-lipoic acid (ALA) derivative, dihydrolipoyl histidinate zinc complex (DHLHZn) for acute lung injury (ALI) and to investigate the mechanism of action.
LPS were administered intratracheally in the DHLHZn(-) group and the DHLHZn(+) group. Four hours after LPS administration, BALF and lung tissue were collected.Total number of cells, number of neutrophils and lymphocytes, levels of various inflammatory cytokines, and NF-kB p65 concentration of BALF were significantly lower in the DHLHZn(+) group than in the DHLHZn(-) group (p=0.05). Thus, Anti-inflammatory effects of DHLHZn for ALI were demonstrated by BALF and histopathological findings.

Report

(3 results)
  • 2017 Annual Research Report   Final Research Report ( PDF )
  • 2016 Research-status Report
  • Research Products

    (2 results)

All 2017 2016

All Journal Article (1 results) (of which Int'l Joint Research: 1 results,  Peer Reviewed: 1 results) Presentation (1 results)

  • [Journal Article] The alpha-lipoic acid derivative DHLHZn: a new therapeutic agent for acute lung injury in vivo.2017

    • Author(s)
      Shoji Y, Takeuchi H, Fukuda K, Fukunaga K, Nakamura R, Takahashi T, Wada N, Kawakubo H, Niyasho T, Hiratsuka T, Inomata M, Betsuyaku T, Kitagawa Y
    • Journal Title

      Inflammation Research

      Volume: 66(9) Issue: 9 Pages: 803-811

    • DOI

      10.1007/s00011-017-1059-x

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed / Int'l Joint Research
  • [Presentation] 急性肺障害に対するαリポ酸誘導体DHLHis-Znの治療効果に関する検討2016

    • Author(s)
      庄司佳晃
    • Organizer
      第116回日本外科学会定期学術集会
    • Place of Presentation
      大阪国際会議場(大阪府大阪市)
    • Related Report
      2016 Research-status Report

URL: 

Published: 2016-04-21   Modified: 2019-03-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi